Prospective study of predictors of mucosal healing in anti-TNF-alpha antibody treatment for inflammatory bowel disease
Not Applicable
Recruiting
- Conditions
- Crohn's disease, Ulcerative colitis
- Registration Number
- JPRN-UMIN000042540
- Lead Sponsor
- Fukuoka University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with serious infections 2) Patients with malignant tumors 3) Patients with severe intestinal stricture, short bowel syndrome, stoma 4) Patients who do not consent to the study 5) Patients who are judged not suitable for this trial by the doctor
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Association with mucosal healing 54 weeks (newly introduced cases) or 56 weeks (maintenance administration cases) after the start of the study (identification of mucosal healing predictors)
- Secondary Outcome Measures
Name Time Method